Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Radu, Christian Andreas [VerfasserIn]   i
 Gebhard, Martha-Maria [VerfasserIn]   i
 Germann, Günter [VerfasserIn]   i
 Terness, Peter [VerfasserIn]   i
Titel:Local administration of Mitomycin-C-Treated peripheral blood mononuclear cells (PBMCs) prolongs allograft survival in vascularized composite allotransplantation
Verf.angabe:Christian Andreas Radu, Jurij Kiefer, Martha Maria Gebhard, Amir Khosrow Bigdeli, Volker Jürgen Schmidt, Guenter Germann, Marcus Lehnhardt, Peter Terness, Ulrich Kneser, andThomas Kremer
Jahr:2016
Umfang:9 S.
Teil:volume:36
 year:2016
 number:5
 pages:417-425
 extent:9
Fussnoten:Published online: 17 November 2015 ; Gesehen am 02.02.2018
Titel Quelle:Enthalten in: Microsurgery
Ort Quelle:New York, NY [u.a.] : Wiley-Liss, 1979
Jahr Quelle:2016
Band/Heft Quelle:36(2016), 5, Seite 417-425
ISSN Quelle:1098-2752
Abstract:Background: VCA offers a potential treatment for extensive tissue defects. First results of systemic administration of Mitomycin C-treated PBMCs in VCA demonstrated a significant prolongation of allograft survival. The aim of this study is to evaluate if local administration of MMC-PBMCs prolongs allograft survival in allogeneic hind limb transplantations of the rat. Methods: Sixty allogeneic hind limb transplantations in the rat were performed in six groups. Lewis rats (LEW) were used as hind limb donors and Brown-Norway rats (BN) as recipients. Animals in group A received donor-derived MMC-treated PBMCs locally (i.m.). Group B received no immunosuppressive therapy, group C received a standard immunosuppressive regime consisting of FK506 and Prednisolon, group D (BN to BN) comprised isograft transplantations without immunosuppressive treatment, group E received non-treated PBMCs (i.m.) and group F received phosphate buffered saline (PBS) without cells. The transplanted hind limbs were assessed for color, edema, skin, hair condition, and consistency of the thigh every 8 hours. Results: Rejection in group A was delayed to an average of 7.2 ± 0.6 days. Survival times were significantly prolonged (P < 0.01) compared to control groups B, E, and F (5.5 ± 0.7, 5.8 ± 0.7, and 5.7 ± 0.5 days). Control groups C and D showed no signs of rejection. Conclusion: The findings of this study show that local administration of MMC-PBMCs has no side effects and significantly extends allograft survival. Further experiments with MMC-PBMCs treatments repeated at different time-points and being added to low dose immunosuppressive protocols need to be performed to improve experimental and eventually clinical outcome after VCA. © 2015 Wiley Periodicals, Inc. Microsurgery 36:417-425, 2016.
DOI:doi:10.1002/micr.30003
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext ; Verlag: http://dx.doi.org/10.1002/micr.30003
 Volltext: http://onlinelibrary.wiley.com/doi/10.1002/micr.30003/abstract
 DOI: https://doi.org/10.1002/micr.30003
Datenträger:Online-Ressource
Sprache:eng
K10plus-PPN:1568033591
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68216457   QR-Code
zum Seitenanfang